Martin McKibbin
- Ophthalmology top 0.2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Molecular Biology top 10%
- Genetics top 10%
- Epidemiology top 10%
- Co-authors
- Ashish AgrawalRobert L. JohnstonChris F. InglehearnRichard GaleAdnan TufailMoin MohamedBruno ZuberbühlerManuel Saldaña
- Topics
- Retinal Diseases and Treatments (58 papers)Retinal Imaging and Analysis (38 papers)Retinal Development and Disorders (27 papers)
- Partner nations
- United KingdomUnited StatesEgypt
In The Last Decade
Martin McKibbin
100 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 111
- Ophthalmology 2.1k
- Radiology, Nuclear Medicine and Imaging 1.2k
- Molecular Biology 969
- Genetics 300
- Epidemiology 298
Countries citing papers authored by Martin McKibbin
This map shows the geographic impact of Martin McKibbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin McKibbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin McKibbin more than expected).
Fields of papers citing papers by Martin McKibbin
This network shows the impact of papers produced by Martin McKibbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin McKibbin. The network helps show where Martin McKibbin may publish in the future.
Co-authorship network of co-authors of Martin McKibbin
This figure shows the co-authorship network connecting the top 25 collaborators of Martin McKibbin. A scholar is included among the top collaborators of Martin McKibbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin McKibbin. Martin McKibbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 2 | |
| 11 | 2 | |
| 12 | 11 | |
| 13 | 43 | |
| 14 | 5 | |
| 15 | 11 | |
| 16 | 1 | |
| 17 | 9 | |
| 18 | 16 | |
| 19 | Improved Response To Ranibizumab In Ex And Current Smokers With Age-related Macular Degeneration (AMD), But No Evidence That CFH, ARMS2/HTRA1 Or VEGF Genotypes Predict Treatment Outcome | 3 |
| 20 | 7 |
About Martin McKibbin
Martin McKibbin is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 104 papers that have together received 2.9k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (58 papers), Retinal Imaging and Analysis (38 papers) and Retinal Development and Disorders (27 papers). The work is most often cited by research in Ophthalmology (2.1k citations), Radiology, Nuclear Medicine and Imaging (1.2k citations) and Molecular Biology (969 citations). Martin McKibbin has collaborated with scholars based in United Kingdom, United States and Egypt. Frequent co-authors include Ashish Agrawal, Robert L. Johnston, Chris F. Inglehearn, Richard Gale, Adnan Tufail, Moin Mohamed, Bruno Zuberbühler, Manuel Saldaña, Rehna Khan and Manir Ali. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.